获取电话?腺瘤性结肠息肉病蛋白2抗体Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The adenomatous polyposis syndromes, familial adenomatous polyposis (FAP) and Gardner’s syndrome (GS), are characterized by numerous adenomatous polyps throughout the entire colon. These polyps 腺瘤性结肠息肉病蛋白2抗体invariably progress to colon cancer in addition to other extracolonic manifestations. The cloning of the APC gene revealed a ubiquitously expressed protein, 2843 amino acids in length, which is frequently mutated in patients suffering from FAP and GS. APC has been found to be associated with structural components of intracellular junctions. b-catenin and g-catenin (also called plakoglobin) 腺瘤性结肠息肉病蛋白2抗体are involved in the regulation of cellular adhesion. APC and E cadherin compete for binding to specific internal regions of both b- and g-catenin. Interactions between cytoskeleton and the APC, E cadherin, b/g catenin complex are mediated by a-catenin.
Also known as:
腺瘤性结肠息肉病蛋白2抗体Adenomatous polyposis coli protein 2; Adenomatous polyposis coli protein-like; APCL; APC2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human APCL/APC2.
●
Predicted Molecular Weight: 244kDa.
腺瘤性结肠息肉病蛋白2抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl049Mu01干扰素γ(IFNγ)多克隆抗体Polyclonal Antibody to Interferon Gamma (IFNg)
kl049Ra01干扰素γ(IFNγ)多克隆抗体Polyclonal Antibody to Interferon Gamma (IFNg)
kl146Hu01血管内皮生长因子D(VEGFD)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl146Mu01血管内皮生长因子D(VEGFD)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl146Ra01血管内皮生长因子D(VEGFD)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl145Hu01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Mu01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Ra01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl144Hu01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl144Mu01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl144Ra01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl143Hu01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Mu01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Ra01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl949Hu01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl949Mu01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl949Ra01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl218Hu01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Mu01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
